# Cogitativo

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cogitativo

- Industry: Software
- Headquarters: Berkeley, US
- Website: www.cogitativo.com
- Total disclosed funding: $17M
- Latest round: Series B (Nov 6, 2019)
- Investors on record: 2

## About

Cogitativo, Inc. is a technology company specializing in AI-driven precision health solutions that leverage advanced data science to manage chronic health conditions in healthcare settings.Founded in 2014 in Berkeley, US, Cogitativo, Inc. focuses on AI-driven health solutions. The company raised USD 17.14 mn in Series B funding in November 2019, led by Wells Fargo Strategic Capital, with Claritas Capital also participating. The total amount raised by the company stands at USD 17.14 mn with a current valuation of USD 121.86 mn. The company has completed 2 deals since inception.Cogitativo specializes in AI-driven precision health solutions that leverage advanced data science to address chronic health conditions. Their flagship platform, Visión, integrates with healthcare providers, utilizing a "Challenge Question" method to derive actionable insights. The company serves a diverse clientele, notably within the United States, including government health agencies and healthcare providers.Cogitativo's revenue model is centered on B2B transactions through partnerships with healthcare organizations. The company's contracts typically involve subscription-based pricing for access to their analytics tools, alongside project-based fees for tailored services aimed at specific client challenges. Their operational framework emphasizes responsible AI governance and ethical practices, fostering trust among partners and clients.Following the Series B funding round on November 6, 2019, in which the company raised USD 17.14 mn, Cogitativo plans to enhance its product offerings and expand into new markets. The recent funding will be allocated towards the development of new AI-driven solutions and increasing their market presence, particularly in regions with growing healthcare demands. Specific timelines and additional details on product launches are to be determined as they navigate their strategic growth initiatives.

## Funding rounds

- Series B, Nov 6, 2019, $17M — Claritas Capital, Wells Fargo Strategic Capital

## Investors

- Claritas Capital (https://capitalatlas.ai/funds/claritas-capital) — Series B
- Wells Fargo Strategic Capital — Series B